Mariana Salatino

Consejo Nacional De Investigaciones Científicas Y Técnicas, B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

A Developmental Lectin-Glycan Program Enables Early Breast Cancer Dissemination and Metastatic Onset.

A Developmental Lectin-Glycan Program Enables Early Breast Cancer Dissemination and Metastatic Onset.

Journal: bioRxiv : the preprint server for biology

Published: May 13, 2026

Buenos Aires Breast Cancer Symposium 2024: bridging basic and clinical research in breast cancer.

Buenos Aires Breast Cancer Symposium 2024: bridging basic and clinical research in breast cancer.

Journal: Medicina

Published: June 27, 2025

Correction: Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells.

Correction: Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells.

Journal: Oncogene

Published: September 08, 2023

A single-step, rapid, and versatile method for simultaneous detection of cell surface glycan profiles using fluorochrome-conjugated lectins.

A single-step, rapid, and versatile method for simultaneous detection of cell surface glycan profiles using fluorochrome-conjugated lectins.

Journal: Glycobiology

Published: June 25, 2023

Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells.

Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells.

Journal: Immunity

Published: September 06, 2022

Untangling Galectin-Mediated Circuits that Control Hypoxia-Driven Angiogenesis.

Untangling Galectin-Mediated Circuits that Control Hypoxia-Driven Angiogenesis.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: March 23, 2022

Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells.

Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 19, 2021

Reprogramming the tumor metastasis cascade by targeting galectin-driven networks.

Reprogramming the tumor metastasis cascade by targeting galectin-driven networks.

Journal: The Biochemical journal

Published: November 29, 2020

Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity.

Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity.

Journal: Cancer research

Published: April 29, 2020

Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression.

Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression.

Journal: The Journal of experimental medicine

Published: August 05, 2019

Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer.

Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer.

Journal: Cancer cell

Published: February 14, 2018

Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments.

Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: March 06, 2015

Showing 1-12 of 21

Last Updated: 09/26/2026